Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer
Clinical trial NCT05089643 · UNKNOWN
Trial details
- NCT number
- NCT05089643
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2019-04-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.